The clinicopathological significance and ethnic difference of FHIT hypermethylation in non-small-cell lung carcinoma: a meta-analysis and literature review

References

• RamalingamSBelaniCSystemic chemotherapy for advanced non-small cell lung cancer: recent advances and future directionsOncologist200813Suppl 151318263769
   PubMed Web of Science ®Google Scholar
• ZhouHGaoSNguyenNNStringent homology-based prediction of H. sapiens-M. tuberculosis H37Rv protein-protein interactionsBiol Direct20149524708540
   PubMed Web of Science ®Google Scholar
• ZhouHJinJZhangHYiBWozniakMWongLIntPath – an integrated pathway gene relationship database for model organisms and important pathogensBMC Syst Biol20126Suppl 2S2
   PubMedGoogle Scholar
• PortalDZhouHZhaoBEpstein-Barr virus nuclear antigen leader protein localizes to promoters and enhancers with cell transcription factors and EBNA2Proc Natl Acad Sci U S A2013110185371854224167291
   PubMed Web of Science ®Google Scholar
• DelpuYCordelierPChoWCTorrisaniJDNA methylation and cancer diagnosisInt J Mol Sci201314150291505823873296
   PubMed Web of Science ®Google Scholar
• MaXWangYWZhangMQGazdarAFDNA methylation data analysis and its application to cancer researchEpigenomics2013530131623750645
   PubMed Web of Science ®Google Scholar
• Ghavifekr FakhrMFarshdousti HaghMShanehbandiDBaradaranBDNA methylation pattern as important epigenetic criterion in cancerGenet Res Int2013201331756924455281
   PubMedGoogle Scholar
• FleischhackerMDietrichDLiebenbergVFieldJKSchmidtBThe role of DNA methylation as biomarkers in the clinical management of lung cancerExpert Rev Respir Med2013736338323964627
   PubMed Web of Science ®Google Scholar
• OhtaMInoueHCotticelliMGThe FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancersCell1996845875978598045
   PubMed Web of Science ®Google Scholar
• PekarskyYCampiglioMSiprashviliZNitrilase and Fhit homologs are encoded as fusion proteins in Drosophila melanogaster and Caenorhabditis elegansProc Natl Acad Sci U S A199895874487499671749
   PubMed Web of Science ®Google Scholar
• RomeroIMartinezMGarridoCThe tumour suppressor Fhit positively regulates MHC class I expression on cancer cellsJ Pathol201222736737922451343
   PubMed Web of Science ®Google Scholar
• PichiorriFPalumboTSuhSSFhit tumor suppressor: guardian of the preneoplastic genomeFuture Oncol2008481582419086848
   PubMed Web of Science ®Google Scholar
• HassanMINaiyerAAhmadFFragile histidine triad protein: structure, function, and its association with tumorogenesisJ Cancer Res Clin Oncol201013633335020033706
   PubMed Web of Science ®Google Scholar
• PekarskyYPalamarchukAHuebnerKCroceCMFHIT as tumor suppressor: mechanisms and therapeutic opportunitiesCancer Biol Ther2002123223612432269
   PubMed Web of Science ®Google Scholar
• HuangQLiuZXieFFragile histidine triad (FHIT) suppresses proliferation and promotes apoptosis in cholangiocarcinoma cells by blocking PI3K-Akt pathwayScientificWorldJournal2014201417969824757411
   PubMedGoogle Scholar
• RimessiAMarchiSFotinoCIntramitochondrial calcium regulation by the FHIT gene product sensitizes to apoptosisProc Natl Acad Sci U S A2009106127531275819622739
   PubMed Web of Science ®Google Scholar
• TrapassoFPichiorriFGaspariMFhit interaction with ferredoxin reductase triggers generation of reactive oxygen species and apoptosis of cancer cellsJ Biol Chem2008283137361374418319262
   PubMed Web of Science ®Google Scholar
• TanSSunCWeiXQuantitative assessment of lung cancer associated with genes methylation in the peripheral bloodExp Lung Res20133918219023614702
   PubMed Web of Science ®Google Scholar
• VerriCRozLConteDFragile histidine triad gene inactivation in lung cancer: the European Early Lung Cancer projectAm J Respir Crit Care Med200917939640119096006
   PubMed Web of Science ®Google Scholar
• CantorJPIliopoulosDRaoASEpigenetic modulation of endogenous tumor suppressor expression in lung cancer xenografts suppresses tumorigenicityInt J Cancer2007120243117019711
   PubMed Web of Science ®Google Scholar
• HanSYIliopoulosDDruckTCpG methylation in the Fhit regulatory region: relation to Fhit expression in murine tumorsOncogene2004233990399815007387
   PubMed Web of Science ®Google Scholar
• McShaneLMAltmanDGSauerbreiWTaubeSEGionMClarkGMReporting recommendations for tumor marker prognostic studies (REMARK)J Natl Cancer Inst2005971180118416106022
   PubMed Web of Science ®Google Scholar
• SteelsEPaesmansMBerghmansTRole of p53 as a prognostic factor for survival in lung cancer: a systematic review of the literature with a meta-analysisEur Respir J20011870571911716177
   PubMed Web of Science ®Google Scholar
• DerSimonianRLairdNMeta-analysis in clinical trialsControl Clin Trials198671771883802833
   PubMed Web of Science ®Google Scholar
• HigginsJPThompsonSGDeeksJJAltmanDGMeasuring inconsistency in meta-analysesBMJ200332755756012958120
   PubMed Web of Science ®Google Scholar
• DerSimonianRMeta-analysis in the design and monitoring of clinical trialsStat Med19961512371248 discussion 49–528817798
   PubMed Web of Science ®Google Scholar
• EggerMDavey SmithGSchneiderMMinderCBias in meta-analysis detected by a simple, graphical testBMJ19973156296349310563
   PubMed Web of Science ®Google Scholar
• HarounRAZakharyNIMohamedMRAbdelrahmanAMKandilEIShalabyKAAssessment of the prognostic value of methylation status and expression levels of FHIT, GSTP1 and p16 in non-small cell lung cancer in Egyptian patientsAsian Pac J Cancer Prev2014154281428724935385
   PubMed Web of Science ®Google Scholar
• LiWDengJTangJXCombined effects methylation of FHIT, RASSF1A and RARbeta genes on non-small cell lung cancer in the Chinese populationAsian Pac J Cancer Prev2014155233523725040980
   PubMed Web of Science ®Google Scholar
• Zochbauer-MullerSFongKMMaitraA5′ CpG island methylation of the FHIT gene is correlated with loss of gene expression in lung and breast cancerCancer Res2001613581358511325823
   PubMed Web of Science ®Google Scholar
• HsuHSChenTPHungCHCharacterization of a multiple epigenetic marker panel for lung cancer detection and risk assessment in plasmaCancer20071102019202617876837
   PubMed Web of Science ®Google Scholar
• YanagawaNTamuraGOizumiHEndohMSadahiroMMotoyamaTInverse correlation between EGFR mutation and FHIT, RASSF1A and RUNX3 methylation in lung adenocarcinoma: relation with smoking statusAnticancer Res2011311211121421508367
   PubMed Web of Science ®Google Scholar
• SongHYiJZhangYWangRChenLDNA methylation of tumor suppressor genes located on chromosome 3p in non-small cell lung cancerZhongguo Fei Ai Za Zhi201114233238 Chinese21426665
   PubMedGoogle Scholar
• LiWDengJJiangPTangJAssociation of 5′-CpG island hypermethylation of the FHIT gene with lung cancer in southern-central Chinese populationCancer Biol Ther201010997100020814237
   PubMed Web of Science ®Google Scholar
• LiHZhangWLiWYinCEffects of methylation of FHIT gene on it’s protein and mrna expression in non-small cell lung cancerZhongguo Fei Ai Za Zhi200912760764 Chinese20719151
   PubMedGoogle Scholar
• YanagawaNTamuraGOizumiHPromoter hypermethylation of RASSF1A and RUNX3 genes as an independent prognostic prediction marker in surgically resected non-small cell lung cancersLung Cancer20075813113817606310
   PubMed Web of Science ®Google Scholar
• KimDSChaSILeeJHAberrant DNA methylation profiles of non-small cell lung cancers in a Korean populationLung Cancer2007581617532092
   PubMed Web of Science ®Google Scholar
• KimJSKimJWHanJShimYMParkJKimDHCohypermethylation of p16 and FHIT promoters as a prognostic factor of recurrence in surgically resected stage I non-small cell lung cancerCancer Res2006664049405416618724
   PubMed Web of Science ®Google Scholar
• NakataSSugioKUramotoHThe methylation status and protein expression of CDH1, p16(INK4A), and fragile histidine triad in nonsmall cell lung carcinoma: epigenetic silencing, clinical features, and prognostic significanceCancer20061062190219916598757
   PubMed Web of Science ®Google Scholar
• IliopoulosDGulerGHanSYFragile genes as biomarkers: epigenetic control of WWOX and FHIT in lung, breast and bladder cancerOncogene2005241625163315674328
   PubMed Web of Science ®Google Scholar
• TomizawaYIijimaHNomotoTClinicopathological significance of aberrant methylation of RARbeta2 at 3p24, RASSF1A at 3p21.3, and FHIT at 3p14.2 in patients with non-small cell lung cancerLung Cancer20044630531215541815
   PubMed Web of Science ®Google Scholar
• TzaoCTsaiHYChenJTChenCYWangYC5′CpG island hypermethylation and aberrant transcript splicing both contribute to the inactivation of the FHIT gene in resected non-small cell lung cancerEur J Cancer2004402175218315341994
   PubMed Web of Science ®Google Scholar
• KimJSKimHShimYMHanJParkJKimDHAberrant methylation of the FHIT gene in chronic smokers with early stage squamous cell carcinoma of the lungCarcinogenesis2004252165217115231689
   PubMed Web of Science ®Google Scholar
• MaruyamaRSugioKYoshinoIMaeharaYGazdarAFHypermethylation of FHIT as a prognostic marker in nonsmall cell lung carcinomaCancer20041001472147715042681
   PubMed Web of Science ®Google Scholar
• JeongYJJeongHYLeeSMBongJGParkSHOhHKPromoter methylation status of the FHIT gene and Fhit expression: association with HER2/neu status in breast cancer patientsOncol Rep2013302270227823969757
   PubMed Web of Science ®Google Scholar
• Al-TemaimiRAJacobSAl-AliWThomasDAAl-MullaFReduced FHIT expression is associated with mismatch repair deficient and high CpG island methylator phenotype colorectal cancerJ Histochem Cytochem20136162763823797051
   PubMed Web of Science ®Google Scholar
• BanzaiCNishinoKQuanJPromoter methylation of DAPK1, FHIT, MGMT, and CDKN2A genes in cervical carcinomaInt J Clin Oncol20141912713223494221
   PubMed Web of Science ®Google Scholar
• PaluszczakJMisiakPWierzbickaMWozniakABaer-DubowskaWFrequent hypermethylation of DAPK, RARbeta, MGMT, RASSF1A and FHIT in laryngeal squamous cell carcinomas and adjacent normal mucosaOral Oncol20114710410721147548
   PubMed Web of Science ®Google Scholar
• YinDTWangLSunJAssociation of the promoter methylation and protein expression of Fragile Histidine Triad (FHIT) gene with the progression of differentiated thyroid carcinomaInt J Clin Exp Pathol2010348249120606729
   PubMed Web of Science ®Google Scholar
• YanagawaNOsakabeMHayashiMTamuraGMotoyamaTFrequent epigenetic silencing of the FHIT gene in penile squamous cell carcinomasVirchows Arch200845237738218299890
   PubMed Web of Science ®Google Scholar
• LeeEJLeeBBKimJWAberrant methylation of Fragile Histidine Triad gene is associated with poor prognosis in early stage esophageal squamous cell carcinomaEur J Cancer20064297298016564166
   PubMed Web of Science ®Google Scholar
• ZhengSMaXZhangLHypermethylation of the 5′ CpG island of the FHIT gene is associated with hyperdiploid and translocation-negative subtypes of pediatric leukemiaCancer Res2004642000200615026336
   PubMed Web of Science ®Google Scholar
• CecenerGTuncaBEgeliUThe promoter hypermethylation status of GATA6, MGMT, and FHIT in glioblastomaCell Mol Neurobiol20123223724421928112
   PubMed Web of Science ®Google Scholar
• WaliAFHIT: doubts are clear nowScientificWorldJournal2010101142115120563537
   PubMedGoogle Scholar
• AndrianiFRozECaseriniRInactivation of both FHIT and p53 cooperate in deregulating proliferation-related pathways in lung cancerJ Thorac Oncol2012763164222425911
   PubMed Web of Science ®Google Scholar
• TakadaSMoritaKHayashiKMethylation status of fragile histidine triad (FHIT) gene and its clinical impact on prognosis of patients with multiple myelomaEur J Haematol20057550551016313263
   PubMed Web of Science ®Google Scholar
• WuQShiHSuoZNeslandJM5′-CpG island methylation of the FHIT gene is associated with reduced protein expression and higher clinical stage in cervical carcinomasUltrastruct Pathol20032741742214660280
   PubMed Web of Science ®Google Scholar
• ShimadaYSatoFWatanabeGLoss of fragile histidine triad gene expression is associated with progression of esophageal squamous cell carcinoma, but not with the patient’s prognosis and smoking historyCancer20008951110896994
   PubMed Web of Science ®Google Scholar